About OKYO OKYO Pharma Limited (NASDAQ: OKYO) is a clinical stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain and dry eye disease, with ...

Chemotherapy appears to activate a stress-sensing system inside immune cells. According to new research from Weill Cornell Medicine and Wake Forest ...

Researchers discovered that chemotherapy can accidentally trigger a stress alarm in immune cells, causing inflammation that ...

Chemotherapy activates a stress sensor in immune cells, triggering inflammation and nerve damage, which may help explain why many cancer patients experience debilitating pain as a side effect, ...

OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with ...